INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Autologous Therapies in the Pharmaceutical Industry—the World’s Most Challenging Supply Chains?

Autologous Therapies in the Pharmaceutical Industry—the World’s Most Challenging Supply Chains?

My presentation to Cool Logistics, all about gene therapy supply chains

Hedley Rees's avatar
Hedley Rees
Oct 20, 2023
∙ Paid
5

Share this post

INSIDE PHARMA
INSIDE PHARMA
Autologous Therapies in the Pharmaceutical Industry—the World’s Most Challenging Supply Chains?
Share

Some good news at last

Hasn’t been much in the way of good news over the last 3 years, for the world or my company PharmaFlow. Once the plandemic hit, advice on good practices in building and running biopharmaceutical supply chains was replaced by a long list of lucrative ‘projects’.

Prior to that, I was frequently asked to present at conferences—my CV here will give you an idea.

BUT….the good news is I’m back on the circuit! A few weeks ago I gave a virtual presentation to the 15th Cool logistics global Conference:

Autologous Therapies in the Pharmaceutical Industry—the World’s most Challenging Supply Chains?

Cool Logistics

For those wondering what Cool Logisitcs is, it’s about transportation and storage of temperature sensitive goods, ones we would consider ‘perishable’. Food, flowers, fish fingers—anything that needs to be chilled and kept that way until it reaches it’s destination.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share